[go: up one dir, main page]

BRPI0803893A2 - processo da sìntese de cefdinir - Google Patents

processo da sìntese de cefdinir

Info

Publication number
BRPI0803893A2
BRPI0803893A2 BRPI0803893-7A BRPI0803893A BRPI0803893A2 BR PI0803893 A2 BRPI0803893 A2 BR PI0803893A2 BR PI0803893 A BRPI0803893 A BR PI0803893A BR PI0803893 A2 BRPI0803893 A2 BR PI0803893A2
Authority
BR
Brazil
Prior art keywords
cefdinir
synthesis process
acid derivatives
synthesis
cefining
Prior art date
Application number
BRPI0803893-7A
Other languages
English (en)
Inventor
Antonio Manca
Mauro Filippi
Bruno Maurizio Sala
Riccardo Ambrogio Monguzzi
Giovanni Fogliato
Original Assignee
Acs Dobfar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acs Dobfar Spa filed Critical Acs Dobfar Spa
Publication of BRPI0803893A2 publication Critical patent/BRPI0803893A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCESSO DA SìNTESE DE CEFDINIR. A presente invenção refere-se à preparação de cefdinir pela síntese de novos intermediários essenciais, isoláveis como espécie variavelmente submetida a solvato complexa com derivados de ácido tiofosfórico ou com derivados de ácido fosfórico.
BRPI0803893-7A 2007-08-06 2008-08-05 processo da sìntese de cefdinir BRPI0803893A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001628A ITMI20071628A1 (it) 2007-08-06 2007-08-06 Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati

Publications (1)

Publication Number Publication Date
BRPI0803893A2 true BRPI0803893A2 (pt) 2009-06-16

Family

ID=39951589

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0803893-7A BRPI0803893A2 (pt) 2007-08-06 2008-08-05 processo da sìntese de cefdinir

Country Status (6)

Country Link
EP (1) EP2030975A1 (pt)
KR (1) KR20090014985A (pt)
CN (1) CN101362769A (pt)
BR (1) BRPI0803893A2 (pt)
IT (1) ITMI20071628A1 (pt)
ZA (1) ZA200806049B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101565427B (zh) * 2009-06-11 2011-04-27 浙江昂利康制药有限公司 头孢地尼的制备方法
CN102020664B (zh) * 2010-11-30 2012-12-12 浙江工业大学 一种头孢地尼的合成方法
CN103012433B (zh) * 2012-12-13 2015-06-24 珠海保税区丽珠合成制药有限公司 头孢地尼晶型b的制备方法
CN103554137B (zh) * 2013-10-31 2015-07-15 哈药集团制药总厂 一种头孢地尼微粉的制备方法
CN106279207A (zh) * 2016-08-15 2017-01-04 苏州中联化学制药有限公司 一种头孢地尼的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA885709B (en) 1987-08-19 1989-04-26 Fujisawa Pharmaceutical Co Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
US4935508A (en) 1988-08-23 1990-06-19 Bristol-Myers Company Process for cephem prodrug esters
TW212181B (pt) 1992-02-14 1993-09-01 Hoechst Ag
KR950013578B1 (ko) 1993-04-10 1995-11-09 주식회사럭키 신규 티아(디아)졸 초산의 반응성 티오포스페이트 유도체 및 그의 제조방법
DK0874853T3 (da) 1995-12-27 2002-09-23 Hanmi Pharmaceutical Co Ltd Fremgangsmåde til fremstilling af cefdinir
US5906098A (en) 1996-07-16 1999-05-25 Turbodyne Systems, Inc. Motor-generator assisted turbocharging systems for use with internal combustion engines and control method therefor
ITMI20020913A0 (it) 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
ITMI20022076A1 (it) * 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.

Also Published As

Publication number Publication date
ZA200806049B (en) 2009-10-28
CN101362769A (zh) 2009-02-11
ITMI20071628A1 (it) 2007-11-05
KR20090014985A (ko) 2009-02-11
EP2030975A1 (en) 2009-03-04

Similar Documents

Publication Publication Date Title
ECSP12011909A (es) Derivados de glicósido y usos de los mismos
MX2019003738A (es) Compuestos antivirales.
CO7141404A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
ECSP13012612A (es) Derivados de quinazolin-4-(3h)-ona utilizados como inhibidores de p13 cinasa
CO6511283A2 (es) Primidinas sustituidas útiles en el tratamiento de enfermedades tales como cancer
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
BR112012021865A2 (pt) derivados de ceto benzofurano, assim com o respectivo processo de síntese e os intermediários.
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
PH12012500634A1 (en) Processes for preparing of glucopyranosyl -substituted benzyl -benzene derivatives
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
BR112013011593A2 (pt) cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
GT201000015A (es) Sulfonamidas como moduladores de trpms
BR112014004219A2 (pt) pirano[3,2-d][1,3]tiazol como inibidores de glicosidase
BRPI0817747A8 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BR112012019302A2 (pt) imidazo[1,2-b][1,2,4]triazinas como inibidores de c-met
UY32481A (es) Derivados de benzofurano
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
BRPI0821102A2 (pt) Preparação de derivados de di-hidropirrol como intermediários
BR112012013119A2 (pt) derivados de 1-amino-piperidina-pirrolidina-diona espirocondensada com atividade pesticida.
BRPI0803893A2 (pt) processo da sìntese de cefdinir
BR112015015229A8 (pt) processo para a preparação de um composto da fórmula, e, composto
CO7141402A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
BR112012017126A2 (pt) derivados de aminoalquilpirimidina como antagonistas de receptor de h4 de histamina
BRPI0908396A2 (pt) quinolinas como inibidores de farnesil pirofosfato sintase

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]